JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms
{{output}}
JAK2 is a tyrosine kinase gene that plays an essential role in the development of normal haematopoiesis. Hyperactivation of JAK2 occurs in myeloproliferative neoplasms by different mechanisms. As a consequence, JAK2 inhibitors have been designed to suppress th... ...